BR005-036C not checked

Brise Pharmaceuticals Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
2 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Migraine, With or Without Aura (2 trials)
Main trialPhase 3
“The purpose of this study is to evaluate the long-term safety of BR005-036C tablets in the acute treatment of migraines”In the company’s words, NCT07835152 on ClinicalTrials.gov

Other drugs for Migraine, With or Without Aura

All 14 drugs for Migraine, With or Without Aura

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting 31 Mar 2029 Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
Phase 2/3Recruiting 30 Jun 2028 Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow BR005-036C

Following is part of Solo: you see every change to BR005-036C the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in